×
About 1,338 results

ALLMedicine™ Idiopathic Thrombocytopenic Purpura Center

Research & Reviews  268 results

Fitness to Serve in the Armed Forces and Internal Medicine: A Retrospective Study.
https://doi.org/10.1093/milmed/usac092
Military Medicine; Lhaiba M, Caré W et. al.

Apr 13th, 2022 - Assessment of the medical fitness to serve in the armed forces has two objectives: to prevent the military operations from being jeopardized by a medical issue, and to protect soldiers from the sequelae of diseases that could become complicated in...

Safety and Efficacy of Fecal Microbiota Transplantation
https://clinicaltrials.gov/ct2/show/NCT04014413

Feb 14th, 2022 - The gut microbiota is critical to health and functions with a level of complexity comparable to that of an organ system. Dysbiosis, or alterations of this gut microbiota ecology, have been implicated in a number of disease states. Fecal microbiota...

Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT
https://clinicaltrials.gov/ct2/show/NCT03421392

Feb 1st, 2022 - Idiopathic thrombocytopenic purpura (ITP) is the most frequent auto-immune cytopenia. There is no specific biological marker and the diagnosis often results from the exclusion of other differential diagnoses, notably inherited thrombocytopenia. Re...

Impact of target-mediated drug disposition on hetrombopag pharmacokinetics and pharmaco...
https://doi.org/10.1111/bcp.15130
British Journal of Clinical Pharmacology; Wang Z, Zeng Z et. al.

Oct 28th, 2021 - The pharmacokinetics (PK) of hetrombopag were found to be nonlinear across evaluated dose ranges. The aim of this study was to develop a mechanism-based population pharmacokinetic/pharmacodynamic (PopPK/PD) model and to provide a reasonable expect...

see more →

Guidelines  1 results

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
https://doi.org/10.1038/ajg.2016.563
The American Journal of Gastroenterology; Chey WD, Leontiadis GI et. al.

Jan 11th, 2017 - Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important cause of peptic ulcer disease and gastric cancer. H. pylori may also have a role in uninvestigated and functional dyspepsia, ulcer risk in patients taki...

see more →

Drugs  216 results see all →

Clinicaltrials.gov  19 results

Safety and Efficacy of Fecal Microbiota Transplantation
https://clinicaltrials.gov/ct2/show/NCT04014413

Feb 14th, 2022 - The gut microbiota is critical to health and functions with a level of complexity comparable to that of an organ system. Dysbiosis, or alterations of this gut microbiota ecology, have been implicated in a number of disease states. Fecal microbiota...

Study of Platelets Sialylation by Flow Cytometry for the Differential Diagnosis of ICT
https://clinicaltrials.gov/ct2/show/NCT03421392

Feb 1st, 2022 - Idiopathic thrombocytopenic purpura (ITP) is the most frequent auto-immune cytopenia. There is no specific biological marker and the diagnosis often results from the exclusion of other differential diagnoses, notably inherited thrombocytopenia. Re...

Safety and Efficacy Study of PG2 to Treat Idiopathic Thrombocytopenic Purpura (ITP) Patients
https://clinicaltrials.gov/ct2/show/NCT00860600

Apr 1st, 2021 - The primary objective of this exploratory study is to evaluate the efficacy of PG2 in raising the platelet counts in ITP patients using two dosing schedules. The secondary objective is to determine the safety of PG2 treatment among these patients.

Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"
https://clinicaltrials.gov/ct2/show/NCT03219723

Mar 22nd, 2019 - The drug being tested in this study is called Vonoprazan (Takecab). Vonoprazan is being tested to treat people who have gastric ulcer, duodenal ulcer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, idiopathic thrombocytopenic purpura, ...

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
https://clinicaltrials.gov/ct2/show/NCT00441090

Mar 7th, 2018 - This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled, dose-ranging, parallel-group study. The pharmacokinetic (PK) and pharmacokinetic/pharmacodynamic (PK/PD) relationship of avatrombopag will also be studied. Approximatel...

see more →

News  27 results

Fast Five Quiz: Management of Helicobacter pylori
https://reference.medscape.com/viewarticle/965518

Jan 25th, 2022 - Helicobacter pylori is one of the most common chronic bacterial infections worldwide. Approximately half of the global population is believed to be infected with H pylori. It is a significant cause of peptic ulcer disease and gastric cancer, which...

Immune-Mediated Diseases Tied to Risk of Cancer
https://www.medscape.com/viewarticle/964508

Dec 10th, 2021 - NEW YORK (Reuters Health) - Immune-mediated diseases were associated with an increased risk of local and systemic cancers, as well as total cancers, in a large cohort study, supporting the role of local and systemic immunoregulation in the develop...

Steroid Combination Therapy & New ASH Guidelines
https://www.onclive.com/view/steroid-combination-therapy-and-new-ash-guidelines

Apr 2nd, 2021 - Transcript: Ivy Altomare, MD: Not considering someone an acutely ill patient but, rather, a regular patient that does need treatment, who you’re treating in the outpatient setting—we are using steroids as appropriate first-line treatment. Are ...

Treating Refractory Idiopathic Thrombocytopenic Purpura
https://www.onclive.com/view/treating-refractory-idiopathic-thrombocytopenic-purpura

Apr 2nd, 2021 - For High-Definition, Click In chronic refractory idiopathic thrombocytopenic purpura (ITP), Howard A. Liebman, MD, pursues strategies that minimize the use of long-term immunosuppressant agents. Keith McCrae, MD, considers thrombopoietin recepto...

Thrombopoietin Receptor Agonists for ITP
https://www.onclive.com/view/thrombopoietin-receptor-agonists-for-itp

Apr 2nd, 2021 - For High-Definition, Click Idiopathic thrombocytopenic purpura (ITP) is a disease of both increased platelet destruction in the peripheral blood and diminished platelet production, explains Keith McCrae, MD. The survival of a platelet in an in...

see more →

Patient Education  4 results see all →